KARD · Kardigan, Inc.
$20.20
-1.61 (-7.38%)
At close · Aug 14
Going-concern doubt
— cleared Aug 11, 2026
The latest filing states the doubt was alleviated.
“the Company previously concluded that recurring losses, negative cash flows from operations, and limited liquidity raised substantial doubt about its ability to continue as a going concern. In June 2026, the Company completed its IPO and received net proceeds of approximately $422.4 million. Upon closing of the IPO and receipt of the associated net proceeds, the Company alleviated the substantial doubt that previously existed.”View the 10-Q filed Aug 11, 2026
Market Cap
$1.89B
Shares
93.50M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$20.20
Open$21.64
Day$20.00–21.64
Available close range$19.73–25.90
Avg vol 30d261K
Short int1.6M · 1.7% float · 6.7d
Short vol41%
DataJun 2026–Aug 2026
Filing10-Q · Aug 11
The closing range uses available history since Jun 18, 2026; less than a full year is stored.
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed Aug 11, 2026
Equibles Rating
blended score · not investment adviceOverall
Neutral
SellHoldBuy
Technical
Buy
Momentum
Limited
Sentiment
Bullish
Fundamentals
Limited
Quant / Vol
Very High
Market backdrop
VIX 14.3 · calm
Equity put/call 0.52
Technical
price trend
50 / 200-day cross
No cross
RSI (14)
44
neutral
MACD trend
Positive
52-week position
8%
near low
Volume (OBV)
Bullish div.
accumulating
Momentum
relative strength
Not enough data for a confident read.
Sentiment
smart money
Trend (MA cross)
No cross
50/200-day averages unavailable
Institutional flow
Accumulating
+68 funds added
Insider flow
Accumulating
Net +$90.0M over 90 days · 0% sells
Short interest
Falling
1.69% of float · ▼ -5.4% MoM · 6.7 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
68 holders — 13F breadth
Squeeze score
50
elevated · 0–100
Fundamentals
Not enough data for a confident read.
Quant / Vol
risk profile
Volatility
68%
annualized · 1-yr
Max drawdown
−24%
past year
ATR
8.4%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
No cross
Neutral
RSI (14)
44
Neutral
MACD trend
Positive
Bullish
52-week position
8%
Bearish
Volume (OBV)
Bullish div.
Bullish
Market signals — smart money & positioning
Bullish · 3 of 6
Trend (MA cross)
No cross
50/200-day averages unavailable
Institutional flow
Accumulating
+68 funds added
Insider flow
Accumulating
Net +$90.0M over 90 days · 0% sells
Short interest
Falling
1.69% of float · ▼ -5.4% MoM · 6.7 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
68 holders — 13F breadth
Price context
position in its available closing range
Range low $20
Now $20 · 8%
Range high $26
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
KARD
this stock
Kardigan, Inc.
|
$1.89B | — | — | — | 1.7% |
|
ONC
BeOne Medicines Ltd.
|
$513.62B | +14.4% | +22179.2% | 789.7 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$128.19B | +11.6% | +46.2% | 29.5 | 1.6% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$82.72B | +4.1% | +20.8% | 19.9 | 3.3% |
|
ARGX
Argenx SE
|
$52.94B | +1.2% | — | — | 2.1% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| KARD | -1.5% | -4.4% | — | -3.0% | — |
| SPY | +0.4% | +4.5% | +13.8% | +3.9% | +13.9% |
| vs SPY | -1.9% | -8.9% | — | -6.9% | — |
Key facts
CIK
2123613
CUSIP
485925101
13F (30d)
72 filings
70 filers
Visit website
Investor relations